版本:
中国

BRIEF-Gilead Sciences says Nova Scotia lists Epclusa on public drug plan to treat all six genotypes of Chronic Hepatitis C infection

May 1 Gilead Sciences Inc

* Gilead sciences inc - nova scotia lists epclusa on public drug plan to treat all six genotypes of chronic hepatitis c infection

* Effective immediately, nova scotia will provide public access to epclusa (sofosbuvir/velpatasvir) tablets Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐